发明申请
US20160235727A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS
有权
新型吡咯烷衍生的BETA 3 ADRENERGIC RECEPTOR AGONISTS
- 专利标题： NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS
- 专利标题（中）： 新型吡咯烷衍生的BETA 3 ADRENERGIC RECEPTOR AGONISTS
-
申请号： US15026267申请日： 2014-09-29
-
公开(公告)号： US20160235727A1公开(公告)日： 2016-08-18
- 发明人: Kenneth Jay Barr , Mark E. Scott , Christopher F. Thompson , Neville Anthony , Carolyn Michele Cammarano , Raman Kumar Bakshi , Subhendu Kumar Mohanty , Chandra Sekhar Korapala , Prashant R. Latthe , Vyjayanthi N. Kambam , Sujit Kumar Sarkar , Jayanth Thiruvellore Thatai
- 申请人： Kenneth Jay Barr , Mark E. Scott , Christopher F. Thompson , Neville Anthony , Carolyn Michele Cammarano , Raman Kumar Bakshi , Subhendu Kumar Mohanty , Chandra Sekhar Korapala , Prashant R. Latthe , Vyjayanthi N. Kambam , Sujit Kumar Sarkar , Jayanth Thiruvellore Thatai
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 国际申请： PCT/US14/57950 WO 20140929
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; C07C53/18 ; C07D401/14 ; C07D413/14 ; A61K31/444 ; A61K31/517 ; A61K31/497 ; A61K31/501 ; C07D471/04 ; C07D495/04 ; A61K31/519 ; C07D401/06 ; C07C53/06
摘要：
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of us ing the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
公开/授权文献
- US09486448B2 Pyrrolidine derived beta 3 adrenergic receptor agonists 公开/授权日：2016-11-08
信息查询
IPC分类:
